You are here

  • Home
  • Archive
  • Volume 72, Issue 8
  • Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Citation Tools

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Leibovitzh H, Lee S, Raygoza Garay JA Crohn’s and Colitis Canada (CCC) Genetic, Environmental, Microbial (GEM) Project Research Consortium, et al
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
Gut 2023;72:1462-1471.